Sunday, March 16, 2025
HomeIndustriesHealthcare

Healthcare

U.S. FDA Approves RINVOQ® (upadacitinib) to Treat Adults and Children 12 Years and Older with Refractory, Moderate to Severe Atopic Dermatitis

AbbVie announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib) for the treatment of moderate to severe atopic dermatitis in adults...

Jacobio Receives IND Approval for Aurora A Inhibitor JAB-2485 from FDA

Jacobio's self-developed global first-in-class drug Aurora A inhibitor JAB-2485 received IND (Investigational New Drug) from the FDA (Food and Drug Administration) in US. Jacobio...

Lightsense Technology and Pure Norwegian Seafood Join Forces to Develop Solutions for Detection of Bacterial Pathogens in Salmon Processing

Lightsense Technology, a pioneer in developing multi-spectroscopic solutions to address critical problems in public health—from the opioid crisis to the Covid-19 pandemic, as well...

Green Valley Obtains IND Approval from U.S. FDA for Sodium Oligomannate’s Global Phase II Clinical Trial in Treating Parkinson’s Disease

On January 13, 2022, Green Valley (Shanghai) Pharmaceuticals Co., Ltd. received the letter from the US Food and Drug Administration (FDA) on the Investigational...

Kaiser Permanente Joins Graphite Health to Accelerate Digital Transformation of Health Care

Graphite Health, a member-led company intent on transforming digital health care to improve patient outcomes and lower costs, announced today that Kaiser Permanente is...
0FansLike
0FollowersFollow
spot_img

Hot Topics